Site US10023 — Lebanon, New Hampshire

Site US10023 is a clinical research site located in Lebanon, New Hampshire, United States 03756-1000.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10023 has participated in 1 clinical trials.

Therapeutic areas: Leukemia, Acute Myeloid (AML).

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10023?

Site US10023 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10023 conducted?

Site US10023 has 1 clinical trials on record. Their work covers Leukemia, Acute Myeloid (AML).

Is Site US10023 accredited by Crixeo Health?

Site US10023 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10023?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.